CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,731,000 | -35.8% | 338,000 | -10.6% | 0.02% | -32.4% |
| Q2 2019 | $2,695,000 | -79.3% | 378,000 | -61.3% | 0.03% | -79.5% |
| Q1 2019 | $12,988,000 | +68.7% | 978,000 | 0.0% | 0.17% | +40.7% |
| Q4 2018 | $7,697,000 | -27.5% | 978,000 | +2.1% | 0.12% | -16.3% |
| Q3 2018 | $10,615,000 | +68.3% | 958,000 | +103.8% | 0.14% | +41.0% |
| Q2 2018 | $6,308,000 | +98.2% | 470,000 | +91.8% | 0.10% | +85.2% |
| Q1 2018 | $3,183,000 | +156.3% | 245,000 | +81.5% | 0.05% | +157.1% |
| Q4 2017 | $1,242,000 | – | 135,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |